Is levofloxacin-based triple therapy an alternative for first-line eradication of Helicobacter pylori? A systematic review and meta-analysis

By Xiao Shu-Ping   Gu Min   Zhang Guo-Xin  

Scandinavian Journal of Gastroenterology, Vol. 49, Iss. 5, 2014-05 ,pp. : 528-538

Informa Healthcare

Access to resources Recommend Favorite

Comparison of Levofloxacin- and Moxifloxacin-Based Triple Therapies with Standard Treatment in Eradication of Helicobacter Pylori as First-Line Therapy

By  

Digestion, Vol. 90, Iss. 4, 2014-12 ,pp. : 261-264

Karger

Access to resources Recommend Favorite

Efficacy and Tolerability of Rifampicin-Based Rescue Therapy for Helicobacter Pylori Eradication Failure in Peptic Ulcer Disease

By Ahuja Vineet   Bhatia Vikram   Dattagupta S.   Raizada Akshay   Sharma Mahesh  

Digestive Diseases and Sciences, Vol. 50, Iss. 4, 2005-04 ,pp. : 630-633

Springer Publishing Company

Access to resources Recommend Favorite

A Better Cure Rate with 800 mg than with 400 mg Clarithromycin Regimens in One-Week Triple Therapy for Helicobacter pylori Infection in Cigarette-Smoking Peptic Ulcer Patients

By  

Digestion, Vol. 75, Iss. 2-3, 2007-05 ,pp. : 63-68

Karger

Access to resources Recommend Favorite

One Week of Esomeprazole Triple Therapy vs. 1 Week of Omeprazole Triple Therapy Plus 3 Weeks of Omeprazole for Duodenal Ulcer Healding in Helicobacter pylori-Positive Patients

By Subei Iyad   Cardona Hector   Bachelet Ernesto   Useche Emerson   Arigbabu Anthony   Hammour Adnan   Miller Tom  

Digestive Diseases and Sciences, Vol. 52, Iss. 6, 2007-06 ,pp. : 1505-1512

Springer Publishing Company

Access to resources Recommend Favorite